MAPT and Alzheimer disease: To explain the failure to control the progression of the AD in immunized mice by both DNA-Tau and MVA-Tau vaccine candidates, we suggest that the expression of the human tau proteins (either Tau4R2N or Tau3RC) in immune cells may result in a loss of proliferation due to the microtubule stabilization promoted by these proteins.